What is Lunai Bioworks Inc. (LNAI) stock price today?

Lunai Bioworks Inc. (LNAI) currently trades at $0.33 per share. The stock has a market capitalization of $11.19M and a P/E ratio of —x.

Is LNAI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Lunai Bioworks Inc. has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -98.36.

Is Lunai Bioworks Inc. financially healthy?

Lunai Bioworks Inc.'s Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -98.36 places it in the distress.

LNAI

Lunai Bioworks Inc.

NASDAQ: LNAI · HEALTHCARE · BIOTECHNOLOGY

$0.33

-0.81% today

Updated 2026-04-30

Market cap

$11.19M

P/E ratio

—

P/S ratio

70,327.55x

EPS (TTM)

$-7.56

Dividend yield

—

52W range

$0 – $4

Volume

24.1M

Market cap

$11.19M

P/E ratio

—

P/S ratio

70,327.55x

EPS (TTM)

$-7.56

Dividend yield

—

52W range

$0 – $4

Volume

24.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-98.4

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity -0.21x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -98.36 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.07M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-113.43M	$-39.68M	$-88.43M	$-178.01M	$-1.80M
EPS	—	—	—	—	$-7.56
Free cash flow	$-15.74M	$-11.80M	$-11.04M	$-7.87M	$-1.07M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LNAI	$11.19M	26	4.3	3.0	5.0	4.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Lunai Bioworks Inc. trades at $0.33. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -98.36, it sits in the distress.

Frequently asked questions

What is Lunai Bioworks Inc.'s stock price?

Lunai Bioworks Inc. (LNAI) trades at $0.33.

Is Lunai Bioworks Inc. overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Lunai Bioworks Inc. (LNAI)?

The analyst target price is $—, representing NaN% downside from the current price of $0.33.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-98.36 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.lunaibioworks.com

Quick metrics

P/S ratio70,327.55x

ROE-366.40%

Beta0.50

50D MA$0.38

200D MA$1.25

Shares out0.04B

Float0.02B

Short ratio—

Avg volume24.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LNAI vs LLY →LNAI vs JNJ →LNAI vs ABBV →Stock screener →